Bio-Rad Laboratories | BIO - Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.22M 478K 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Danaher USD 707.7M 800K 2026-03
General Electric Aerospace USD 1.04B 5.43M 2026-03
Illumina USD 151.91M 893K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Laboratory Of America USD 82.3M 100K 2026-03
Merck USD 2.47B 12.72M 2025-12
Mettler Toledo International USD 20.25M 179.94K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Repligen USD 56.4M 74K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Siemens EUR 780.74M 6.33M 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Tosoh JPY 307.89M 2.47M 2026-03
Waters USD 98.17M 89K 2026-03